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22. Isoelectric focusing gels contained 4% (v/v) ofpH 5
to 7 and 1% (v/v) ofpH 3 to 10 carrier ampholyte
[Servalyt (Serva)], 9M urea, and 2% Triton X-100
(16). After incubation in 2% SDS, 10% glycerin,
and 60 mM tris (pH 6.8) for 15 min, gels were run
on a discontinuous SDS-PAGE system with a linear
gradient of 5 to 20%. Proteins were electroblotted
onto nitrocellulose, membranes were blocked for 1
hour (0.05M tris (pH 7.5), 0.5% casein, and 0.5%
Tween 20), incubated for 12 hours at 4°C with
MAb IAIO, washed in blocking buffer, and incubat-
ed for 1 hour with alkaline phosphatase-conjugated
goat antibody to mouse immunoglobulin G (Pro-
mega, Biotec Madison). Blots were developed with
98 p.M nitrobluetetrazolium, 92 p.M 5-bromo-4-
chloro-3-indolyl phosphate in IM diethanolamine,
and 0.5 mM MgCI2, pH 9.8.
23. The method used for the generation of tryptic
peptides was as follows. The r-65-kD hsp ofM. bovis
was isolated from E. coli M1103 (4) containing the
full-length gene of 65-kD hsp in the expression
vector pPLc 236. The soluble constituents of bacte-
ria were fractionated by ammonium sulfate precipi-
tation. The precipitate that formed between 20%
and 55% saturation of ammonium sulfate was
bound on the anion exchanger Q-Sepharose Fast
Flow (Pharmacia) in 50 mM tris, pH 8.0, and the
65-kD hsp was eluted with a linear gradient of 0 to
0.3M NaCl. For trypsin digestion, the 65-kD hsp
was treated with 8M urea, and after dialyzing against
0.1M ammonium bicarbonate, up to 100 mg of
protein was cleaved overnight at room temperature
with 25 U of immobilized trypsin [N-tosyl-L-phe-
nylalanine chloromethyl ketone-treated, attached to
beaded agarose, (Sigma)]. Ovalbumin was denatur-
ated and trypsinized as described (18).
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Primary Structure of the 0i Subunit of the DHP-
Sensitive Calcium Channel from Skeletal Muscle
PETER RUTH, AXEL ROHRKASTEN, MARTIN BIEL, EVA BOSSE,
STEFAN REGULLA, HELMUT E. MEYER, VEIT FLocKERzI,*
FRANz HOFMANN
Complementary DNAs for the ,B subunit of the dihydropyridine-sensitive calcium
channel of rabbit skeletal muscle were isolated on the basis of peptide sequences
derived from the purified protein. The deduced primary structure is without homology
to other known protein sequences and is consistent with the ( subunit being a
peripheral membrane protein associated with the cytoplasmic aspect of the sarcolem-
ma. The protein contains sites that might be expected to be preferentialiy phosphory-
lated by protein kinase C and guanosine 3',5'-monophosphate-dependent protein
kinase. A messenger RNA for this protein appears to be expressed in brain.
T HE DIHYDROPYRIDINE (DHP)-SEN-
sitive Ca2+ channel seems to play an
important role in excitation-contrac-
tion coupling, and when purified from rab-
bit skeletal muscle, it contains three main
subunits with molecular masses of 165,000
(a,), 55,000 (13), and 32,000 daltons (-y)
(1-9). Both the a1 and the 13 subunits are
substrates for protein kinases in vitro, and
phosphorylation of these subunits may serve
to regulate the in vivo function of the Ca2+
channel (1-5). A disulfide-linked dimer of
130,000- (a2) and 28,000-dalton (8) poly-
peptides has been observed in preparations
of the channel either in variable (6) or
constant (7) amounts with respect to the
other subunits. The subunits have been re-
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constituted and form functional Ca2+ chan-
nels that are modulated by phosphorylation
(10) and by monospecific antibodies for the
al, 1, and y subunits (11). The a, polypep-
tide is the principal transmembrane subunit
ofthe channel and forms the ion-conducting
pore (12). This polypeptide binds DHPs,
phenylalkylamines, and benzothiazepines (1,
2, 6-9) and is readily phosphorylated in
vitro at Ser587 by adenosine 3',5'-mono-
phosphate (cAMP)-dependent protein ki-
nase (4). Microinjection of an expression
plasmid carrying the al-subunit cDNA re-
stores a DHP-sensitive Ca2+ current and
excitation-contraction coupling in dysgenic
muscle (13). It is not known whether these
functions require the presence of the other
channel subunits. The a2 polypeptide has
been cloned (14) and is present in dysgenic
muscle cells (15), which may also contain the
1 and y subunits.
We now report the primary structure of
the 1 subunit from rabbit skeletal muscle as
deduced from cloned cDNA and the tissue
distribution ofthe corresponding mRNA. A
total of eight peptides, six of which were
unique, were isolated from two separate
proteolytic digests of the isolated 1 subunit
(16). In one case the purified channel con-
taining the ,B subunit was phosphorylated by
cAMP-dependent protein kinase before sep-
aration of the subunits. Peptide 1 contained
32% of the recovered radioactivity (recov-
ered radioactivity was 74% of the radioac-
tivity initially present in the ,B subunit). The
remaining radioactivity was associated with
several peptides. Four oligodeoxyribonu-
cleotides, each containing 14 nucleotides
(nt), which were complementary to all pos-
sible cDNA sequences encoding the amino
acid sequence Asp-Met-Met-Gln-Lys (ex-
cluding the third nucleotide residue of the
Lys codon) in peptide 2, were synthesized.
These oligomers were used as specific prim-
ers for reverse transcription of the 1-subunit
mRNA. An equimolar mixture of 64 syn-
thetic 14-nt oligodeoxyribonucleotides,
which were complementary to all the possi-
ble cDNA sequences corresponding to the
amino acid sequence Gly-Tyr-Glu-Val-Thr
(excluding the third nucleotide residue of
the Thr codon) in peptide 2, was used to
probe 2 x 105 transformants. Two clones,
pCaCH,Bl-I and pCaCH,B10-I, which both
contained the coding region for part of
peptide 2, were isolated. In addition, clone
pCaCHIl-I contained the cDNA encoding
peptides 1, 3, 4, and 7. This clone was used
as a probe for cloning larger cDNA se-
quences (Fig. 1A).
The 1835-nt cDNA sequence obtained
contains an open reading frame encoding a
sequence of 524 amino acids (Fig. 1B). The
calculated molecular mass of 57,868 daltons
is similar to that estimated by SDS-poly-
acrylamide gel electrophoresis (55 kD). The
cDNA contains all sequenced peptides. The
NH2-terminus of the isolated C subunit was
blocked and could not be sequenced. We
selected the first methionine (amino acid 1)
rather than the second methionine (amino
acid 7) as the translation initiation site be-
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cause it is the first in frame ATG triplet that
appears downstream ofthe stop codon TGA
(nucleotides -51 to -49) and because the
nucleotide sequence surrounding this initia-
tion codon agrees with the consensus se-
quence for eukaryotic initiation codons, ex-
cept for the nucleotide at position -3 where
a T substitutes for a purine. This substitu-
tion is frequently linked with a nonfunction-
al upstream ATG codon (17), and such a
codon is found at nucleotides -57 to -55.
An analysis of the amino acid sequence of
the ,B subunit for local hydropathicity (Fig.
1C) reveals the absence of a typical mem-
A
-1_y 500 1000
brane-spanning region (segments of at least
19 residues with an average hydropathicity
index of greater than 1.6) (18). Additional-
ly, the NH2-terminal sequence does not
resemble a hydrophobic signal sequence.
The protein appears to be hydrophilic, al-
though it contains hydrophobic regions.
These properties are consistent with bio-
chemical data suggesting that the 13 subunit
does not interact with the cell membrane
but is tightly associated with an intracellular
domain of the a1 subunit (2). As judged by
the probabilistic method of Garnier et al.
(19), the 13 subunit contains four major a-
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Secondary 0
structure
D F L
V K E v 1% r. %aLo r I + b r Fig. 1. (A) Cloning and sequencingL R L L Q E Q K L R O S R strategy for thej subunit. The pro-
SGDNSSSSLGDVV tein-coding region is indicated by aP To P P A S G N E M T N L closed box. The extent of cDNA
P L D IL E E D E A E LI G E inserts of the individual clones (32)
K T S V S S V T T P P P H used for sequence analysis (33) (in-
F F K K T E H V P P Y D V dicated by arrows) are shown by
P I I L V G P S L K G Y E thick lines. (B) Deduced amino
K A L F D F L K H R F D acid sequence of the P subunit.
T R V T A D I S L A KR S Cloning procedures, if not stated
S K H I I I E R S N T R S otherwise, were carried out as de-
Q S E I E R I F E L A R T scribed (34). The six peptides deter-
L D A D T I N H P A Q L S mined by sequence analysis are un-
P I I V Y I KI T S* P K V derlined. Similar stretches of eight
K S R G K S Q S K H L N V amino acids, contained in the long
E K L A Q C P P E M F D I oa helices, are boxed. Predictedphosphorylation sites for proteinQ IL E D A C E H L A E Y L kinase C (*), cGMP-dependent
A T H P P S S T P P N P L protein kinase (+), casein kinase II
A T A A L A A S P A P V s (#), and cAMP-dependent protein
VLTS* .LRRNLS FWG kinase (0) are indicated. Site phos-G phorylated by cAMP-dependentQ R G G G A V P Q Q Q E H protein kinase (O) is identified. Po-
tential N-glycosylation sites (K) are
at amino acid positions 189, 470,
200 300 400 500 and 499. (C) Hydropathy profile
and predicted secondary structure,
computed according to Kyte and
Doolittle (18); the window size is
19 residues, plotted at one-residue
intervals. The positions of predict-f1 Jllll Allr t#itf114 d ed secondary structures (stretches
of ten or more amino acids) are
shown: long a helices (I, II, III,
and IV, solid boxes), short a helices
(dotted boxes), and . sheets (open11II1 IV boxes)
helical domains, which have been designated
I (amino acids 73 to 101), II (amino acids
212 to 237), III (amino acids 344 to 371),
and IV (amino acids 414 to 455) (Fig. 1C).
The arrangement of hydrophobic residues
within domains II, III, and IV resembles a
heptad repeat, in which most of the first and
fourth residues ofevery seven are hydropho-
bic (for example, amino acids 418, 422,
425, 429, 432, 436, 439, 443, 446, 450,
and 453 in domain IV). Such heptad repeats
of hydrophobic residues are thought to par-
ticipate in interactions between cytoskeletal
proteins (20). By the use of the Dayhoff
MDM 78 matrix (21), the 1 subunit shows
weak relatedness to some isoforms of actin,
keratin, glial fibrillary acidic protein, myo-
sin, and tropomyosin with alignment scores
of 1.6 to 1.9. Each a-helical domain con-
tains a similar stretch of eight amino acids
(boxed in Fig. 1B), which starts and ends
with Leu or Ile and is interdispersed by
negatively charged residues. This arrange-
ment of acidic residues may function in the
binding of divalent cations. The 13 subunit
specifically binds Ca2+ with low affinity
(apparent dissociation constant 1 mM)
(22) as measured by the method ofHummel
and Dreyer (23). This low affinity may be
due to the isolation procedure, which in-
cludes a denaturation step. No sequence
similarity was found between the 13 subunit
and the EF-hand of high-affinity Ca2+-bind-
ing proteins or with calsequestrin (24).
Several potential phosphorylation sites
are present in the 13 subunit; this finding is
consistent with in vitro phosphorylation
studies (1-5). The serine (Ser'82) of peptide
1 was phosphorylated in vitro by cAMP-
dependent protein kinase, although the ami-
no acid sequence around this phosphor-
ylation site does not contain the basic motif
Arg-Arg-X-Ser (where X represents any ami-
no acid) typical of substrates of this enzyme
(25). Another potential phosphorylation site
for cAMP-dependent protein kinase is
Thr205, which is preceded by the sequence
Arg-Arg-Pro. The time course of phosphate
incorporation into the 13 subunit catalyzed
by cAMP-dependent protein kinase in vitro
is slow (3), and so phosphorylation of these
residues may not be physiologically relevant.
The 13 subunit is also phosphorylated by
both protein kinase C and guanosine 3',5'-
monophosphate (cGMP)-dependent pro-
tein kinase, and at least three different tryp-
tic phosphopeptides have been identified
(3). Two of these peptides were phosphory-
lated both by protein kinase C and by
cAMP-dependent protein kinase (2, 3).
There are 12 potential phosphorylation sites
for protein kinase C [(Ser or Thr)-X-(Arg or
Lys)] (26) in the 13 subunit (Fig. 1B). Analy-
sis of the trypsin cleavage sites in the pri-
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mary structure identifies two potential tryp-
tic peptides (amino acids 181 to 185 and
203 to 240) that contain phosphorylation
sites for both kinases (Fig. iB). Protein
kinase C increases the number of Ca2+
channels in skeletal muscle and fibroblasts
(27). There is also evidence that cGMP-
dependent protein kinase alters Ca2+ chan-
nel function in specific neurons of Helix
aspersa and cardiac muscle (28). The cGMP-
dependent protein kinase phosphorylates at
least one site in the 1 subunit that is not
phosphorylated by protein kinase C (3).
The ,B-subunit sequence Arg-X-Ser179-Arg is
a potential phosphorylation site for cGMP-
dependent protein kinase (25). The presence
of at least two regions that are rich in proline
(P), glutamine (E), serine (S), and threo-
nine (T) (amino acids 67 to 77 and 204 to
239) within the primary structure may ex-
plain the sensitivity of the 1 subunit to
proteases (1-3). These PEST regions are
common to rapidly degraded proteins (29)
and are often targets of casein kinase II.
Ser"', being followed by Asp-Ser-Asp, rep-
resents a potential casein kinase II phos-
phorylation site (25). Casein kinase II phos-
phorylates the 13 subunit apparently at two
sites in vitro (3), and it has been proposed
that these might be constitutive phosphoryl-
ation sites of the channel complex.
The tissue distribution of the mRNA for
the 13 subunit was analyzed by RNA blots of
polyadenylated [poly(A)+] RNA from sev-
eral rabbit tissues (30) (Fig. 2). Various
cDNA fragments derived from both the
noncoding and the coding sequence ofthe 13
subunit were used as probes. The probes
Fig. 2. RNA blot
analysis of rabbit
RNA with ,B-subunit
cDNA probes. Sam-
ples of poly(A)+
RNA (20 ,ug) from
skeletal muscle (SM)
and brain (B) were
denatured with 1M
glyoxal and 50% di-
methyl sulfoxide,
subjected to electro-
phoresis in a 1.5%
agarose gel, and
transferred to Bio-
dyne membranes.
The hybridization
probe was the Sac I
(nucleotide 695)-Pfl
MI (nucleotide
1608) fragment la-
beled by random
priming. Identical re-
sults were obtained
when the Pst I (nu-
cleotide 515)-Ava II
(nucleotide 841) and
Stv I (nucleotides 56
and 389) fragments
were used as probes (22).
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Origin-
28S-
23S-
18S-
16S -
derived from the coding sequence hybrid-
ized to two poly(A)+ RNA species of skele-
tal muscle with estimated sizes of 1900 and
1600 nt. The size of the large species is
consistent with the size ofthe cloned cDNA
(1835 nt). In addition, a cDNA fragment
consisting of most of the 5' noncoding
sequence hybridized to the large species
only. The less abundant and smaller mRNA
may differ in the 5' untranslated sequence as
a result of altemative mRNA processing. In
poly(A)+ RNA from brain, a probe derived
from the coding sequence hybridized to a
species of 3000 nt. The intensity of this
signal was similar to that of the 1900-nt
species in skeletal muscle. No 13 subunit-
specific hybridization was observed with
poly(A)+ RNA from smooth muscle or
heart. Thus homologous, but not identical,
1-subunit mRNAs appear to exist in differ-
ent tissues. The lack ofhybridization signals
from heart and smooth muscle may be due
either to the lower concentration of 13-
subunit mRNA in these tissues or to the
presence of 13 subunits with considerably
different nucleotide sequences. A similar tis-
sue-specific expression was found with the
mRNA encoding the a1 subunit, whereas
the a2-subunit mRNA was detected in all
tissues examined (14).
The primary structure of the 13 subunit
lacks significant homology with any protein
in the Swiss protein and the GenBank nucle-
otide sequence databases. Polypeptides of
similar size as the 13 subunit appear to be
associated with other voltage-activated ion
channels, such as the Na+ channel (2) and
various K+ channels (31). However, the
primary structures ofthese proteins have not
yet been determined.
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of the same priner extension library (approximately
3 x 10 transforrnants) with the Alu I (nt 276)-Pst
I (nt 515) fragment of pCaCh13l-I gave 15 positive
clones induding pCaCh1ll-I (nt 53 to 884) and
pCaCh,B6-I (nt 105 to 884). The Pst I (nt 515)-Ava
II (nt 841) fragment was used for screening approxi-
mately 5 x 105 transformants of an oligo(dT) li-
brary, and one positive clone, pCaCh,Bl-II (nt 635
to 1680), was obtained. Elongation of a third
synthetic primer (1.8 nmol), complementary to nt
144 to 159 [with 30 ,ug of poly(A)+ RNA], and
screening of the resulting clones (approximately
1.5 x 105 transformants) with the Sty I (nt 56)-
Dde I (nt 138) fragment yielded 12 positive clones,
including pCaCh,B8-III (nt -155 to 143). All
clones had an identical length and restriction enzyme
map except pCaCh33-III (nt 34 to 417), which
arose from priming at nt 419 to 434. Sequencing of
the cDNA was performed on both strands (Fig.
1A). In addition, pCaCh,B6-I, pCaCh,Bl-I,
pCaChl10-I, and pCaChP3-III were sequenced.
The nucleotide differences among the individual
clones were as follows: at nt 252, G (pCaCh3ll -I,
pCaCh,Bl-I, and pCaCh(3-III) or A (pCaCh,B6-I);
at nt 438, C (pCaCh1ll-I, pCaCh,B6-I, and
pCaChpl-I) or T (pCaChBO10-I). The differences
did not result in amino acid substitution.
33. F. Sanger et al., Proc. Natl. Acad. Sci. U.S.A. 74,
5463 (1977); A. M. Maxam and W. Gilbert, Methods
Enzymol. 65, 499 (1980).
34. T. Maniatis, E. F. Fritsch, J. Sambrook, Molecular
Cloning: A Laboratory Manual (Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY, 1982).
35. Supported by Deutsche Forschungsgemeinschaft,
Thyssen, and Fond der Chemischen Industrie. The
GenBank accession number of the nucleotide se-
quence of the 1 subunit of the DHP-sensitive
calcium channel is M25817.
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Molecular Characterization
03-Adrenergic Receptor
of the Human
LAuRENT J. EMORINE, STEFANO MARULLO,
MARIE-M. BRIEND-SUTREN, GILLES PATEY, KERI TATE,
COLETrE DELAVIER-KLUTCHKO, A. DONNY STROSBERG
Since the classification of (-adrenergic receptors ((3-ARs) into (3s and (32 subtypes,
additional P-ARs have been implicated in the control ofvarious metabolic processes by
catecholamines. A human gene has been isolated that encodes a third (3-AR, here
referred to as the "(33-adrenergic receptor." Exposure of eukaryotic cells transfected
with this gene to adrenaline or noradrenaline promotes the accumulation ofadenosine
3',5'-monophosphate; only 2 of 11 classical "-AR blockers efficiently inhibited this
effect, whereas two others behaved as (3-AR agonists. The potency order of P-AR
agonists for the P3-AR correlates with their rank order for stimulating various
metabolic processes in tissues where atypical adrenergic sites are thought to exist. In
particular, novel (3-AR agonists having high thermogenic, antiobesity, and antidiabetic
activities in animal models are among the most potent stimulators of the (3-AR.
DRENERGIC RECEPTORS MEDIATE
the physiological actions of the hor-
ones adrenaline and noradrena-
line. Four subtypes of these catecholamine
receptors, the al-, a2-, P13-, and 02-adrener-
gic receptors (al-, a2-, 1I-, and 12-AR) have
been identified on the basis of their pharma-
cological properties and physiological ef-
fects. Chemical agents that selectively block
or stimulate these receptors are used exten-
sively in clinical medicine. Despite the effica-
cy of these compounds, they may produce
side effects, in part because of interaction
with other homologous receptors. Improve-
ment of drug selectivity thus necessitates a
complete characterization of each receptor
that mediates the physiological actions of
catecholamines.
The genes encoding the a,-, a2-, 1PI-, and
132-AR have been isolated (1-4). They be-
long to a family of homologous genes that
encode integral membrane receptors (5, 6),
which presumably have seven membrane-
spanning domains and which are coupled to
regulatory G proteins. Several of the genes
in this family have been characterized, and
probes derived from these genes have been
used to identify additional receptor subtypes
(7, 8).
Additional subtypes of 1-AR have been
suggested to mediate the sympathetic con-
trol of various metabolic processes in the
digestive tract (9, 10), adipose tissue (11-
13), and skeletal muscle (14, 15). Evidence
for the existence of such atypical 13-AR sites
includes their low affinity for standard 1-AR
blockers. Recently, 1-AR agonists have
been synthesized (16) that are potent stimu-
lators of metabolic rate, adipose tissue ther-
mogenesis, ileum relaxation, and soleus
muscle glycogen synthesis (10, 11, 14-16),
but these agonists have minimal effects at P1I
and 132 sites. However, the existence of a 13-
AR different from the currently defined 1,i-
and 132-AR is controversial (17).
We screened a human genomic library
with the entire coding regions of the genes
for the turkey 1l- and the human 132-AR
(18). Among 43 positive clones, two carried
the gene coding for the human (3,-AR and
another two the gene for the P2-AR. A
family of 14 homologous clones (19) dis-
played sequences homologous to both
probes in a 2.1-kb Bam HI-Bgl II fragment.
From one clone, this fragment was entirely
sequenced and shown to contain a gene
coding for a polypeptide of402 amino acids
with a predicted size of 42,881 daltons.
The amino acid sequence of this protein
(Fig. 1) is 50.7 and 45.5% identical to that
of the human 13- and 12-AR, respectively
(the 13I-AR and 12-AR are 48.9% identical).
The protein shares the structural characteris-
tics of receptors of the G protein-linked
family. It has seven clusters of 21 to 27
mostly hydrophobic amino acids, presumed
to constitute a-helical membrane-spanning
domains. These hydrophobic segments form
the catecholamine binding site of the 1-AR
(20) and are highly conserved between the
predicted protein and the two 1-ARs. In
particular, Asp79 and Asp"3 of the 132-AR,
which possibly act as counterions for the
positively charged amine of adrenergic li-
gands, are present at analogous positions in
the three proteins. Similarly, other function-
ally important residues (20), such as Cys106,
Cys'84, Asn318, and Pro323 of the 12-AR
sequence, are conserved. As with other G
protein-linked receptors, the predicted pro-
tein has potential Asn-linked glycosylation
sites in the NH2-terminal region and has Ser
and Thr residues in its third cytoplasmic
loop and COOH-terminal region that could
be substrates for protein kinases, which may
mediate receptor desensitization.
To characterize the product of the cloned
gene, we introduced it into Chinese hamster
ovary (CHO) cells (21). The transfected
cells expressed specific and saturable binding
sites for [1251]iodocyanopindolol ([125I]_
ICYP), a 1-AR ligand (Fig. 2A); the calcu-
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CNRS, Universite Paris VII, and Institut Pasteur, Labo-
ratory of Molecular Biology of Receptors, 25 rue du Dr.
Roux, 75724 Paris Cedex 15, France.
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